ACM
KURA icon

Asymmetry Capital Management’s Kura Oncology KURA Stock Holding History

Asymmetry Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$7.03M Buy
502,275
+307,966
+158% +$4.99M 3.73% 13
2021
Q3 		$3.64M Buy
+194,309
New +$3.66M 2.19% 20
2021
Q2 		– Sell
-277,468
Closed -$7.84M – 31
2021
Q1 		$7.84M Sell
277,468
-69,050
-20% -$2.18M 4.06% 13
2020
Q4 		$11.3M Buy
346,518
+146,034
+73% +$5.13M 5.16% 6
2020
Q3 		$6.14M Buy
+200,484
New +$4.43M 3.95% 12

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Asymmetry Capital Management's KURA Position: Q4 2021 in Review

Asymmetry Capital Management increased its Kura Oncology (KURA) stake by 158% in Q4 2021, buying an estimated $4.99M and bringing the position to 502,275 shares worth $7.03M. The position accounts for 3.73% of the portfolio, ranked #13.

Asymmetry Capital Management first reported a position in KURA in Q3 2020 and has held it in 5 quarters since. The position peaked at $11.3M in Q4 2020. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • Asymmetry Capital Management held 502,275 shares of Kura Oncology worth $7.03M as of Q4 2021.
  • Asymmetry Capital Management bought 307,966 Kura Oncology shares in Q4 2021, an estimated $4.99M.
  • Kura Oncology made up 3.73% of Asymmetry Capital Management's portfolio in Q4 2021, its #13 holding.
  • Asymmetry Capital Management first reported a position in Kura Oncology in Q3 2020 and has held it in 5 quarters since.
  • Asymmetry Capital Management's Kura Oncology position peaked at $11.3M in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.